Euan Ramsay
About Euan Ramsay
Euan Ramsay serves as the Chief Commercial Officer and Co-Founder of Precision NanoSystems Inc., where he has worked since 2018. He has a strong background in drug delivery and gene therapy, with over 20 peer-reviewed publications and significant contributions to securing over $40 million in grant funding.
Work at Precision NanoSystems
Euan Ramsay serves as the Chief Commercial Officer and Co-Founder of Precision NanoSystems Inc., a position he has held since 2018. In this role, he is responsible for overseeing commercial strategies and operations within the company. Prior to his current title, he was the Co-Founder and Chief Operating Officer from 2010 to 2018. Under his leadership, the company has focused on advancing technologies in drug delivery and gene therapy, contributing to significant developments in the life sciences sector.
Education and Expertise
Euan Ramsay earned his Ph.D. in Gene Therapy from Cardiff University, where he studied from 1995 to 1999. He also holds a Bachelor of Science with Honours in Pharmacy from the University of Strathclyde, completed from 1988 to 1992. His educational background provides a strong foundation for his expertise in drug delivery systems and gene therapy, which is reflected in his extensive publication record.
Background in Research and Development
Euan Ramsay has a robust background in research and development, having worked at various prestigious institutions. He was a Senior Scientific Fellow at the BC Cancer Agency from 2001 to 2006 and served as a Visiting Scientist at the University of Tasmania for five months in 2006 to 2007. Additionally, he worked at the Centre for Drug Research and Development (CDRD) as Manager of Business Development in Oncology from 2007 to 2010, where he contributed to advancing oncology drug development.
Achievements in Grant Funding
Throughout his career, Euan Ramsay has played a significant role in securing over $40 million in grant funding. This funding has supported various stages of research and development, particularly in life sciences and drug products. His efforts have facilitated advancements in the field, enabling the development of innovative therapies and technologies.
Intellectual Property Contributions
Euan Ramsay holds four granted patents and has 17 pending patent applications related to drug delivery and gene therapy. His contributions to intellectual property reflect his commitment to innovation in his field and underscore his expertise in developing novel solutions for drug delivery systems.